![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0831.png)
•
BJU Int.
2012 Dec;110(11):1696-701.
•
Secondary cancers after intensity-modulated
radiotherapy, brachytherapy and radical prostatectomy
for the treatment of prostate cancer: incidence and cause-
specific survival outcomes according to the initial
treatment intervention.
•
Zelefsky MJ
1
,
Pei X
,
Teslova T
,
Kuk D
,
Magsanoc JM
,
Kollmeier M
,
Cox B
,
Zh Z ang
.
•
1
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer
Center, New York, NY 10065, USA.
Zelefskm@mskcc.org•
CONCLUSIONS:
•
The incidence of SM after radiotherapy was not
significantly different from that after RP when
adjusted for patient age and smoking history.